Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1992-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.89.21.10075PMID 1359534PMCID PMC50280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein.

  1992cited by this paper
• Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C.

  1992cited by this paper
• Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein.

  1992cited by this paper
• Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.

  1991cited by this paper
• Cytokines in Alzheimer's disease.

  1991cited by this paper
• Interleukin-1 stimulates the beta-amyloid precursor protein promoter

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA.

  1990cited by this paper
• Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

  1990cited by this paper
• Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.

  1990cited by this paper
• Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures.

  1989cited by this paper
• Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II.

  1988cited by this paper
• A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

  1988cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

  1988cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.

  1987cited by this paper
• Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• New perspectives on Alzheimer's disease.

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper
• Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

  1973cited by this paper

• A Novel Competing Endogenous RNA Linked to Dysregulated Neuroinflammation in Alzheimer’s Disease

  2026cites this paper
• Drugs repurposing in the experimental models of Alzheimer’s disease

  2025cites this paper
• The role of regulatory T cells in central nervous system diseases in dogs: fighting with a double-edged sword toward translational discoveries.

  2025cites this paper
• Activation of multifunctional DNA repair APE1/Ref-1 enzyme by the dietary phytochemical Ferulic acid protects human neuroblastoma SH-SY5Y cells against Aβ(25-35)-Induced oxidative stress and inflammatory responses.

  2024cites this paper
• 肥胖与阿尔茨海默病的相关性及其作用机制（英文）

  2024cites this paper
• Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.

  2024cites this paper
• Inflammatory Mechanisms and Treatments of Alzheimer's Disease: An Integrative Review of Neuroscience and Bioinformatics

  2024cites this paper
• Network pharmacology-based approach to elucidate the pharmacologic mechanisms of natural compounds from Dictyostelium discoideum for Alzheimer's disease treatment

  2024cites this paper
• ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery

  2023cites this paper
• Effect of acupuncture on neuroinflammation in animal models of Alzheimer’s disease: A preclinical systematic review and meta-analysis

  2023cites this paper
• Monomeric amyloid-β inhibits microglial inflammatory activity in the brain via an APP/heterotrimeric G protein-mediated pathway

  2023influential citation
• Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

  2023cites this paper
• TonEBP Haploinsufficiency Attenuates Microglial Activation and Memory Deficits in Middle-Aged and Amyloid β Oligomer-Treated Mice

  2023cites this paper
• Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2023cites this paper
• A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology

  2023cites this paper
• Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems

  2022cites this paper
• The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease

  2022cites this paper
• Animal Models of Cognitive Deficits for Probiotic Treatment

  2022cites this paper
• Food Science of Animal Resources

  2022cites this paper
• Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.

  2022cites this paper
• Tannic acid inhibits lipopolysaccharide-induced cognitive impairment in adult mice by targeting multiple pathological features.

  2022cites this paper
• A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease

  2022cites this paper
• ER stress associated TXNIP-NLRP3 inflammasome activation in hippocampus of human Alzheimer's disease.

  2021cites this paper
• Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology

  2021cites this paper
• Inflammasome-mediated neurodegeneration following heart disease

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021cites this paper
• Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events

  2021cites this paper
• Alterations and interactions of subcortical modulatory systems in Alzheimer's disease.

  2021cites this paper
• Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.

  2020cites this paper
• Complex Interaction between Resident Microbiota and Misfolded Proteins: Role in Neuroinflammation and Neurodegeneration

  2020cites this paper
• Gene-environment interaction promotes Alzheimer's risk as revealed by synergy of repeated mild traumatic brain injury and mouse App knock-in.

  2020cites this paper
• The effect of insomnia on development of Alzheimer’s disease

  2020cites this paper
• The crucial Role of Neuroinflammation in the consistency and development of Alzheimer’s Disease

  2020cites this paper
• Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery

  2020cites this paper
• G protein-coupled receptors in neurodegenerative diseases

  2020cites this paper
• The tumor suppressor p53 regulates the expression of the beta-amyloid precursor protein

  2020cites this paper
• M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?

  2020cites this paper
• MR spectroscopy in Alzheimer’s disease

  2020cites this paper
• Heat-Shock Proteins in Neuroinflammation

  2019cites this paper
• Paul Greengard, Ph.D. (1925‐2019)

  2019cites this paper
• Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.

  2019cites this paper
• Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress

  2019cites this paper
• Exercise enhances the effectiveness of vitamin D therapy in rats with Alzheimer’s disease: emphasis on oxidative stress and inflammation

  2019cites this paper
• Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis

  2019cites this paper
• 1–40 b -Amyloid Protein Fragment Modulates the Expression of CD44 and CD71 on the Astrocytoma Cell Line in the Presence of IL1 b and TNF a

  2018cites this paper
• Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease

  2018cites this paper
• Altered Processing of β-Amyloid in SH-SY5Y Cells Induced by Model Senescent Microglia.

  2018cites this paper
• Group I Metabotropic Glutamate Receptors (mGluRs): Ins and Outs.

  2018cites this paper
• Apelin, a promising target for Alzheimer disease prevention and treatment.

  2018cites this paper
• Inflammation as a central mechanism in Alzheimer's disease

  2018cites this paper
• Identifying key regulators of the immune/inflammatory response for developing anticonvulsive and antiepileptogenic approaches

  2017cites this paper
• Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease.

  2017cites this paper
• Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

  2017cites this paper
• Modulation of the Estradiol and Neprilysin Pathways by Resveratrol in a Lipopolysaccharide Model of Cognitive Impairment

  2017cites this paper
• Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.

  2017cites this paper
• Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer’s Disease

  2017cites this paper
• COMBINATION THERAPEUTIC INFLUENCE OF ASPIRIN AND RIVASTIGMINE ON SCOPOLAMINE INDUCED ALZHEIMER’S IN WISTAR RAT

  2017cites this paper
• Cathepsin B plays a critical role in inducing Alzheimer's disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice.

  2017cites this paper
• Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuro-pathological Hallmarks

  2017cites this paper
• Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.

  2016cites this paper
• Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

  2016cites this paper
• G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs

  2016cites this paper
• Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity

  2016cites this paper
• Effect of glatiramer acetate on short‐term memory impairment induced by lipopolysaccharide in male mice

  2016cites this paper
• Alzheimer's Disease: Targeting the Cholinergic System

  2016cites this paper
• Cholinergic Mechanisms in the Cerebral Cortex

  2016cites this paper
• Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis

  2016cites this paper
• The role of pattern recognition receptors in amyloid-beta-induced inflammation

  2016cites this paper
• Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia.

  2015cites this paper
• Cognitive Enhancers and Treatments for Alzheimer's Disease

  2015cites this paper
• PERK REGULATES CALCIUM DYNAMICS IN COGNITION AND NEURODEGENERATIVE DISEASE

  2015cites this paper
• Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors

  2015cites this paper
• Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease.

  2015cites this paper
• Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network

  2015cites this paper
• α-Asarone Ameliorates Memory Deficit in Lipopolysaccharide-Treated Mice via Suppression of Pro-Inflammatory Cytokines and Microglial Activation

  2014cites this paper
• When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.

  2014cites this paper
• Chronic stress as a risk factor for Alzheimer’s disease

  2014cites this paper
• Alleviation of central accumulation of amyloid-beta and prevention of cognitive dysfunction following peripheral inflammation

  2014influential citation
• Therapeutic Effects of Curcumin on Alzheimer's Disease

  2014cites this paper
• Chronic Functional Bowel Syndrome Enhances Gut-Brain Axis Dysfunction, Neuroinflammation, Cognitive Impairment, and Vulnerability to Dementia

  2014cites this paper
• Stress and inflammation: a detrimental combination in the development of neurodegenerative disease

  2014cites this paper
• Sources of Extracellular Tau and its Signaling

  2014cites this paper
• Role of stress, depression, and aging in cognitive decline and Alzheimer's disease.

  2014cites this paper
• Alzheimer’s Disease and Inflammation

  2014cites this paper
• Outline of therapeutic interventions with muscarinic receptor-mediated transmission.

  2014cites this paper
• Silibinin ameliorates LPS-induced memory deficits in experimental animals.

  2014cites this paper
• Celastrol Enhances Cell Viability and Inhibits Amyloid-β Production Induced by Lipopolysaccharide In Vitro

  2014cites this paper
• α7 nicotinic acetylcholine receptors at the glutamatergic synapse

  2014influential citation
• Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors

  2014cites this paper
• Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

  2014cites this paper
• The dark sides of amyloid in Alzheimer's disease pathogenesis

  2014cites this paper
• The Effect of Acute LPS-Induced Immune Activation and Brain Insulin Signaling Disruption in a Diabetic Model of Alzheimer's Disease

  2014cites this paper
• Aggravation of Alzheimer’s disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells

  2014influential citation
• The effects of chronic calcium dysregulation on behavioral and pathological features of Alzheimer's disease

  2013cites this paper
• The neuroinflammatory response in humans after traumatic brain injury

  2013cites this paper
• Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42).

  2013cites this paper
• Microglial interleukin-1 α expression in human head injury: correlations with neuronal and neuritic β -amyloid precursor protein expression

  2013cites this paper
• Identification and characterization of innate immune receptor substrates of γ-secretase enzyme complex

  2013cites this paper
• Review: The long‐term consequences of microglial activation following acute traumatic brain injury

  2013cites this paper
• Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

  2013cites this paper